Artiva Biotherapeutics Insider Trades
NASDAQ: ARTVHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 6.94 0.00%
Last 12 months
- Purchases
- 19 · $17.68M
- Sales
- 12 · $2.00M
- Shares bought / sold
- 2.13M / 218.79K
- Net activity
- Net buying $15.7 million
Artiva Biotherapeutics insider activity
Over the last 12 months, Artiva Biotherapeutics insiders reported 39 transactions on SEC Form 4: 19 open-market purchases and 12 sales. Insiders bought $17.7 million and sold $2.0 million worth of stock, for net insider buying of $15.7 million. The largest seller was Aslan Fred, with $1.5 million in reported sales.
The most recent filing shows Aslan Fred (Chief Executive Officer) selling 23,463 shares at $7.20 on Oct 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ARTV's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ARTV insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 6, 2026 | Aslan FredChief Executive Officer | Sale | 23,463 | $168.88K | Form 4 |
| Oct 5, 2026 | Aslan FredChief Executive Officer | Sale | 61,696 | $421.83K | Form 4 |
| Oct 5, 2026 | Banerjee SubhashisChief Medical Officer | Sale | 1,099 | $7.51K | Form 4 |
| Oct 5, 2026 | Bush JenniferCOO, CLO, Compliance Officer | Sale | 8,370 | $57.23K | Form 4 |
| Oct 5, 2026 | Horan ChristopherChief Tech Operations Officer | Sale | 10,340 | $70.70K | Form 4 |
| Sep 15, 2026 | Aslan FredChief Executive Officer | Award | 110,000 | — | Form 4 |
| Sep 10, 2026 | Aslan FredChief Executive Officer | Award | 45,000 | — | Form 4 |
| Sep 9, 2026 | Banerjee SubhashisChief Medical Officer | Award | 30,000 | — | Form 4 |
| Sep 9, 2026 | Bush JenniferCOO, CLO, Compliance Officer | Award | 45,000 | — | Form 4 |
| Sep 9, 2026 | Horan ChristopherChief Tech Operations Officer | Award | 40,000 | — | Form 4 |
| Sep 9, 2026 | Miralles Gines DiegoPresident & Head of R&D | Award | 45,000 | — | Form 4 |
| Sep 8, 2026 | Aslan FredChief Executive Officer | Sale | 23,429 | $255.75K | Form 4 |
| Sep 3, 2026 | Banerjee SubhashisChief Medical Officer | Sale | 1,100 | $12.27K | Form 4 |
| Sep 3, 2026 | Bush JenniferCOO, CLO, Compliance Officer | Sale | 8,391 | $93.61K | Form 4 |
| Sep 3, 2026 | Horan ChristopherChief Tech Operations Officer | Sale | 10,366 | $115.64K | Form 4 |
| Sep 3, 2026 | Aslan FredChief Executive Officer | Sale | 61,888 | $690.39K | Form 4 |
| Aug 27, 2026 | Banerjee SubhashisChief Medical Officer | Sale | 8,222 | $98.74K | Form 4 |
| Aug 27, 2026 | Banerjee SubhashisChief Medical Officer | Option exercise | 5,306 | $10.19K | Form 4 |
| Aug 18, 2026 | Banerjee SubhashisChief Medical Officer | Sale | 429 | $5.15K | Form 4 |
| Aug 18, 2026 | Banerjee SubhashisChief Medical Officer | Option exercise | 429 | $823.68 | Form 4 |
| Jul 31, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 24,944 | $247.69K | Form 4 |
| Jul 29, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 20,824 | $208.03K | Form 4 |
| Jul 24, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 41,319 | $412.78K | Form 4 |
| Jul 23, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 59,880 | $596.40K | Form 4 |
| Jul 22, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 84,124 | $835.35K | Form 4 |
| Jul 21, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 120,582 | $1.15M | Form 4 |
| Jul 17, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 7,882 | $70.54K | Form 4 |
| Jul 16, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 152,472 | $1.36M | Form 4 |
| Jul 13, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 6,552 | $58.57K | Form 4 |
| Jul 13, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 6,522 | $58.31K | Form 4 |
| Jul 10, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 15,102 | $135.46K | Form 4 |
| Jun 26, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 1,876 | $16.85K | Form 4 |
| Jun 25, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 31,000 | $275.28K | Form 4 |
| Jun 16, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 124,893 | $1.11M | Form 4 |
| Jun 15, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 15,414 | $138.57K | Form 4 |
| Jun 12, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 391,019 | $3.35M | Form 4 |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 548,580 | $4.34M | Form 4 |
| Jun 10, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 103 | $721 | Form 4 |
| Jun 9, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 479,039 | $3.31M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4